Stem cell transplantation (SCT)

PROCEDURE3 trials

Sponsors

Goethe University, M.D. Anderson Cancer Center, Emory University

Conditions

AML, ChildhoodAcute Myeloid LeukemiaAdult Acute Lymphocytic LeukemiaLeukemiaLymphomaMyeloma

Phase 1

Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies

TerminatedNCT00473551

M.D. Anderson Cancer CenterLeukemia, Lymphoma, Myeloma

Start: 2007-05-31End: 2009-11-30Updated: 2011-12-19

Phase 2

AflacLL1901 (CHOA-AML)

TerminatedNCT04326439

Emory UniversityAcute Myeloid Leukemia, AML, Childhood

Start: 2020-01-24End: 2022-03-15Updated: 2022-06-15

Phase 4

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

CompletedNCT00198991

Goethe UniversityAdult Acute Lymphocytic Leukemia

Start: 2003-04-30End: 2013-06-30Updated: 2022-08-18

Related Papers

A strategy to reduce cumulative anthracycline exposure in low-risk pediatric acute myeloid leukemia while maintaining favorable outcomes.

2020-07-121 citations

Adults with Philadelphia chromosome–like acute lymphoblastic leukemia frequently have <i>IGH-CRLF2</i> and <i>JAK2</i> mutations, persistence of minimal residual disease and poor prognosis

Haematologica2016-08-25161 citations

Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL.

2012-09-28342 citations

Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.

2012-03-22349 citations